Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide, but a major
proportion of patients are not appropriate candidates for surgical resection or …

Background & Aims Proton beam radiotherapy (PBT) has recently been applied to treat
hepatocellular carcinoma (HCC); however, there is no randomized controlled trial-based …

Background Recently introduced no-touch radiofrequency ablation (RFA) of hepatocellular
carcinoma (HCC) has the potential to improve local tumor control. Purpose To evaluate …

The first edition of the guidelines for the use of ultrasound contrast agents was published in
2004, dealing with liver applications. The second edition of the guidelines in 2008 reflected …

Introduction Intraoperative navigation during liver resection remains difficult and requires
high radiologic skills because liver anatomy is complex and patient-specific. Augmented …

Purpose To evaluate the technical feasibility and therapeutic outcomes of percutaneous
US/MRI fusion–guided radiofrequency ablation (RFA) of recurrent subcentimeter-sized …

Hepatocellular carcinoma (HCC) is prevalent worldwide with suboptimal therapeutic
outcomes. The advancement of therapeutic options and the development of new systemic …

As medical imaging advancements have improved the detectability of hepatocellular
carcinoma (HCC) in early stages, the approach to percutaneous thermal ablation for curative …

Liver tumour ablation nowadays represents a routine treatment option for patients with
primary and secondary liver tumours. Radiofrequency ablation and microwave ablation are …